TheProfitWatch

CADL - Candel Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
6.0 -0.1 (-1.67%) --- --- 0.0 (0.0%) 0.11 (1.83%) 0.09 (1.62%) 0.07 (1.19%) 0.07 (1.19%)

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.09
Diluted EPS:
-0.09
Basic P/E:
-65.5556
Diluted P/E:
-65.5556
RSI(14) 1m:
100.0
VWAP:
5.9
RVol:
1.0813

Events

Period Kind Movement Occurred At
1m Price decrease 1m 5.86 -0.1 (-1.68%) Oct 15 10:37
1m Price increase 1m 5.96 +0.09 (+1.6%) Oct 14 18:47

Related News